Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.099 USD | +12.50% | +12.50% | -23.67% |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pure Hard Surface
95.2
%
| 1 | 80.8 % | 2 | 95.2 % | +19.23% |
Silverion
4.5
%
| 0 | 17.0 % | 0 | 4.5 % | -73.02% |
Royalty
0.3
%
| 0 | 2.2 % | 0 | 0.3 % | -85.00% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 2 | 100.0 % | 2 | 100.0 % | +1.30% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Robert Bartlett
CEO | Chief Executive Officer | 79 | 23-02-07 |
Mark Elliott
DFI | Director of Finance/CFO | 48 | 03-12-31 |
Dolana Blount
CTO | Chief Tech/Sci/R&D Officer | - | 97-12-31 |
Tom Myers
CTO | Chief Tech/Sci/R&D Officer | 71 | 11-05-08 |
Tom Lee
BRD | Director/Board Member | 75 | 14-10-23 |
John Kasperski
SAM | Sales & Marketing | - | 22-03-31 |
Zhinong Yan
PRN | Corporate Officer/Principal | - | 22-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Bartlett
CEO | Chief Executive Officer | 79 | 23-02-07 |
Tom Myers
CTO | Chief Tech/Sci/R&D Officer | 71 | 11-05-08 |
Tom Lee
BRD | Director/Board Member | 75 | 14-10-23 |
Ivan Chen
CHM | Chairman | 41 | 18-06-27 |
David Rendall
BRD | Director/Board Member | 51 | 21-01-26 |
Bernard Blotner
BRD | Director/Board Member | 73 | 23-02-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 111,856,473 | 66,608,527 ( 59.55 %) | 0 | 59.55 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-23.67% | 11.07M | |
+10.31% | 25.44B | |
+7.38% | 19B | |
-23.51% | 6.49B | |
+6.41% | 6B | |
+5.96% | 3.44B | |
+3.78% | 2.47B | |
-8.20% | 1.94B | |
+23.63% | 946M | |
+0.64% | 803M |
- Stock
- Equities
- Stock PURE Bioscience, Inc. - OTC Markets
- Company PURE Bioscience, Inc.